FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly pediatric surgery and neonatology, and can be used for early diagnosis of ulcerative-necrotic enterocolitis in newborns. Method involves determining fecal calprotectin level in feces in newborns. If the fecal calprotectin level is more than 1.1 mg/g, ulcerous-necrotic enterocolitis is diagnosed.
EFFECT: use of the invention enables reducing lethality in ulcerous-necrotic enterocolitis by optimizing early diagnosis, timely onset of conservative treatment and surgical management.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF EARLY DIAGNOSTICS OF NECROTISING ENTEROCOLITIS IN NEWBORN BABIES | 2012 |
|
RU2524613C2 |
| METHOD FOR INTEGRATED TREATMENT OF NECROTISING ENTEROCOLITIS IN NEWBORNS AND INFANTS | 2013 |
|
RU2527348C1 |
| METHOD OF PREDICTING POSTOPERATIVE PERIOD COURSE IN NEWBORN BABIES AND JUNIOR INFANTS WITH NECROTIC ENTEROCOLITIS | 2011 |
|
RU2476159C2 |
| METHOD FOR THE TREATMENT OF UNCOMPLICATED NECROTIZING ENTEROCOLITIS IN NEWBORNS WITH A BACTERIAL INFECTION AND IF INTRAUTERINE INFECTION IS SUSPECTED | 2021 |
|
RU2771856C1 |
| METHOD OF DIAGNOSIS OF ENTEROCOLITIS OF PREMATURELY BORN CHILDREN | 0 |
|
SU1298665A1 |
| METHOD FOR EARLY DIAGNOSTICS OF NEONATAL SEPSIS | 2021 |
|
RU2755218C1 |
| METHOD FOR TREATING INFLAMMATORY DISEASES OF TERMINAL COLON | 2022 |
|
RU2807235C1 |
| METHOD FOR PREDICTING COURSE OF NECROTIZING ENTEROCOLITIS IN NEWBORN INFANTS | 2014 |
|
RU2585418C2 |
| METHOD FOR ASSESSING INTESTINAL DYSFUNCTION IN NEWBORNS IN CRITICAL CONDITIONS REQUIRING REPLACEMENT THERAPY | 2021 |
|
RU2767276C1 |
| METHOD OF CONDUCTING CHILDREN WITH HIRSPERFLY DISEASE IN PERIOPERATIVE PERIOD | 2018 |
|
RU2694549C1 |
